Endometriosis Clinical Trials

Find Endometriosis Clinical Trials Near You

Evaluate the Therapy of Large Ovarian Endometrioma

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Endometrioma's prevalence is between 23 and 55%. It causes pelvic pain, decrease fertility and ovarian reserve. Currently, there's no recommendation about large endometrioma's treatment and there's no information on the best treatment to limit recurrences, preserve fertility and ovarian reserve. In Lille university hospital, simple laparoscopic drainage associated with hormonal therapy is practiced to reduce the risk of cystectomy. This protocol will be evaluated with an observational and prospective study, including women of childbearing age having endometrioma measuring 6 cm or above. The aim of this study is to assess if cyst drainage associated with GnRH agonist, could decrease endometrioma recurrences, deleterious effect on ovarian reserve and evaluate impact on anti-mullerian hormone

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: f
View:

• Endometrioma size ≥ 6cm determined by MRI or ultrasonography

• Women with isolated endometrioma or other extraovarian endometriosis: peritoneal, infiltrating endometriotic lesions and adenomyosis.

• Cyst single or bilateral

Locations
Other Locations
France
Hop Jeanne de Flandre Chu Lille
RECRUITING
Lisle-sur-tarn
Contact Information
Primary
Chrytèle RUBOD, MD,PhD
chrystele.rubod@chru-lille.fr
0320445962
Time Frame
Start Date: 2021-01-21
Estimated Completion Date: 2026-12
Participants
Target number of participants: 62
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Lille

This content was sourced from clinicaltrials.gov